Objective: Chemotherapy-induced vocal fold motion impairment (CIVFMI) is a rare
complication of cancer therapy with potential for airway compromise. The objective of this …

Introduction: Chemotherapy is a rare cause of iatrogenic vocal fold dysfunction. It has been
reported in three main classes of chemotherapy agents and often occurs during the …

Introduction: Vincristine (VCR) is a chemotherapeutic agent used widely in the treatment of
hematologic and solid tumors, known to result in neurotoxicity, especially with cumulative …

Introduction Anti-angiogenic treatment in adjunct with chemotherapy is widely used for the
treatment of various cancers. These agents inhibit vascular endothelial growth factor (VEGF) …

Background Bilateral vocal cord paralysis is uncommon. Most cases occur secondary to
trauma, malignancy, surgery, or intubation. Also, it was reported as a side effect of Vinca …

Background. Vascular endothelial growth factor/receptor (VEGF/R) inhibitors are used in
chemotherapy protocols to limit tumor angiogenesis. Recent evidence shows they are …

Background As the use of anti-angiogenic treatments is gaining scope in the treatment of
various malignancies, there are increasing reports of laryngeal side effects. We report two …

Background Vincristine, a type of vinca alkaloid, is widely used in the treatment of various
childhood and adult malignancies. A well-known side effect of vincristine is its neurotoxicity …

Background The clinical features of vocal fold immobility (VFI) after radiotherapy for
nasopharyngeal carcinoma (NPC) have seldom been reported. Methods We retrospectively …

Vocal cord paralysis after administration of the chemotherapeutic agent vincristine is a rare
occurrence. Most occurrences are bilateral. Of the 24 cases referenced in this article, 19 are …